Trending...
- 76 FENCE Expands in North Carolina with Strategic Franchise Growth Led by Regional Developer Drew Myers
- Celebrate Christmas 2024 with Exclusive Deals and Festive Offers
- Eva Garland Consulting Expands to New Office Space in Raleigh to Support Growing Accounting Team
INNOVATION PARK, N.C. ~ IQVIA Holdings Inc. (NYSE:IQV) announced today that its wholly-owned subsidiary, IQVIA Inc., has allocated a new term B loan due 2031 of approximately $1,500 million. This loan was upsized due to lender demand.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
The proceeds from the new term loan B and the offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 will be used to repay outstanding Euro-denominated and U.S.-denominated term B loans under the Borrower's senior secured credit facilities, as well as to pay fees and expenses related to the Borrower's Notes offering and the Borrower's credit agreement amendment in respect of the New Term Loan B.
In connection with the allocation of the New Term Loan B, IQVIA entered into a cross-currency swap agreement which will effectively convert the New Term Loan B into a euro-denominated borrowing at prevailing euro interest rates to hedge exposure to USD-denominated indebtedness created by the New Term Loan B. The effective net borrowing rate to IQVIA will be 4.9015%, inclusive of the yield on the New Term Loan B and the beneficial impact of the cross-currency swap.
More on ncarol.com
- Capital Realty Group Has An Outstanding October!
- The United States Environmental Protection Agency (USEPA) is SEBAC's 2024 Award for Excellence winner
- Author Riley G. Staliger Offers Tools to Escape Guilt-Driven Relationships AKA Obligationships Using Pop Culture
- Healthcare Consulting Firm, Coker, Announces Acquisition of NorthGauge Healthcare Advisors
- Kaplan Morrell Named Exclusive Workers' Compensation Firm for Greeley Fire Fighters
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to life sciences industry. It creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is also a global leader in protecting individual patient privacy by using a wide variety of privacy-enhancing technologies and safeguards while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with precise treatment paths for better outcomes.
The company's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances in an effort to advance their path toward cures.
Filed Under: Business
0 Comments
Latest on ncarol.com
- Retired Navy SEAL Launches Barrett Strategic Leadership Group (BSLG)
- Green Office Partner Ranked #1 on Chicago Sun-Times' Best Workplaces List for 2024
- Eyewebsafety Expands Its Safety Eyewear Solutions to the Automotive Industry
- OMI9 Expands Offerings to Create Bulletproof Business Model
- Tarrytown Expocare Pharmacy to Open Florida IDD Pharmacy
- CCHR Demands Apology, Compensation for Racist Mental Health and Eugenics Policies
- PebblePad and NorthEdge Partner to Boost Global Student Success
- 4 Quick Fixes to Get More Customers
- Turning Followers into Customers
- Inc. Names Talentica as a 2024 Power Partner Award Winner
- Are Psychedelics the Missing Keys That Open The Door Of Ancestral Magic?
- Finding Family DNA Podcast Series Wins Gold!
- Allegiant Management Group's Alex Zweydoff, RMP®, Receives 2024 Darrell Kazen Memorial Scholarship at 2024 NARPM® National Convention
- From Tax Advisor to Community Advocate
- The Boy Who Lived... as a Pirate: What Deal Did He Make with the Flying Dutchman?
- Ghostly Gamble: Nick Caden's Deadliest Halloween Mystery Yet
- Cornerstone Hospitality Solutions, Llc Receives Veteran Institute For Procurement Commercial Certification
- Summit Credit Union Reaffirms Commitment to Small Credit Unions and Women's Leadership with New $130,000 Contribution
- Upcoming Webinar: Family-Owned Businesses in Italy and Spain: Opportunities and Pitfalls for International Investors
- WYSIWYG Marketing Welcomes Ellen McColl as Director of Business Development